Both Denmark and Sweden, having launched new national life science strategies, have clearly made life science a national strategic priority. But what is the potential for future Danish-Swedish life science collaboration post the COVID-19 pandemic? Where are the synergies, and how do we leverage them for the benefit of science, industry, healthcare and patients alike? How can Medicon Valley strengthen its position as the leading life science cluster of the Nordics and as a globally attractive destination for life science? These are some of the questions and discussions that will be addressed at this year´s MVA Annual Meeting. We look forward to seeing you there!
Date: Monday November 8, 2021
Time: 12:00 – 18:30
Venue: Clarion Hotel Copenhagen Airport, Ellehammersvej 20, 2770 Kastrup, Denmark
VIEW THE RECORDING
PROGRAM
The program is updated on an ongoing basis.
| 12:00 – 12:30 | Registration and Networking |
| 12:30 | Welcome Søren Bregenholt Chairman of the board, Medicon Valley Alliance / CEO, Alligator Bioscience |
| 12:45 | State of Medicon Valley – Life science in Greater Copenhagen Anette Steenberg CEO, Medicon Valley Alliance |
| 13:00 – 14:00 | Framework conditions for life science and innovation |
| 13:00 | Experience from a serial entrepreneur in life science Mathias Uhlén Professor at Royal Institute of Technology (KTH) and Danish Technical University, Founding Director of SciLifeLab |
| 13:25 | The potential and key framework conditions of the Danish life science sector Brian Mikkelsen CEO, Danish Chamber of Commerce |
| 13:40 | Collaboration in Medicon Valley – Unlocking the potential in Life Science Linn Mandahl General Manager, AbbVie Scandinavia / Vice Chair of the Board of Directors, The Swedish Association of the Pharmaceutical Industry |
| 14:00 | Coffee break |
| 14:30 – 15:30 | Attracting investments |
| 14:30 | Building a strong ecosystem for early stage life science innovation Jens Nielsen CEO, BioInnovation Institute |
| 14:45 | Can we eliminate the Valley of Death in biotech startups? Peter Horn Møller Founder & CEO, Marigold Innovation |
| 15:00 | Controlling the debate: Best practices for attracting US investors/partners in a post-pandemic market Jonathan P. Gertler Managing Director, BioVentures Investors / Managing Partner & CEO, Back Bay Life Science Advisors |
| 15:15 | Lounge discussion |
| 15:30 – 16:00 | Coffee break |
| 16:00 – 17:00 | Innovation through clinical research and private/public partnerships |
| 16:00 | Large data and the opportunity to regain previously lost opportunities – Drug Repurposing as an example Stefan Jovinge Research Director, Skåne University Hospital |
| 16:15 | Innovation to advance cancer care – possibilities and barriers in the Medicon Valley Mef Nilbert Director, Danish Cancer Society Research Center |
| 16:30 | Trial Nation – A Part of the Clinical Research Ecosystem Marianne Pilgaard CEO, Trial Nation |
| 16:45 | Discussion and Q&A |
| 17:00 – 17:40 | Creating and implementing breakthrough technologies Dr. Robert S. Langer MIT Institute Professor, MIT Department of Chemical Engineering |
| 17:40 | Summary and Conclusion Søren Bregenholt Chairman of the board, Medicon Valley Alliance / CEO, Alligator Bioscience |
| 17:45 – 18:30 | Networking & Tapas |
SPEAKERS
The list of speakers will be updated on an ongoing basis.
 |
 |
 |
| Anette Steenberg CEO Medicon Valley Alliance | Mathias Uhlén Professor at Royal Institute of Technology (KTH) and Danish Technical University Founding Director of SciLifeLab | Brian Mikkelsen CEO Danish Chamber of Commerce |
 |
 |
 |
| Linn Mandahl General Manager AbbVie Scandinavia & Vice Chair Board of Directors The Swedish Association of the Pharmaceutical Industry | Jens Nielsen CEO BioInnovation Institute | Peter Horn Møller Founder & CEO Marigold Innovation |
 |
 |
 |
| Jonathan P. Gertler Managing Director, BioVentures Investors Managing Partner & CEO Back Bay Life Science Advisors | Stefan Jovinge Research Director Skåne University Hospital | Mef Nilbert Director Danish Cancer Society Research Center |
 |
 |
|
| Marianne Pilgaard CEO Trial Nation | Dr. Robert S. Langer MIT Institute Professor MIT Department of Chemical Engineering | |
|
MODERATORS |
||
 |
 |
|
| Sarah Lidé Senior Strategy and Project Manager Medicon Valley Alliance | Søren Bregenholt Chairman of the board Medicon Valley Alliance CEO, Alligator Bioscience |
MVA’s Annual meeting is the annual flagship event of Medicon Valley Alliance. We invite prominent regional, national and international speakers to address key topics such as life science innovation, commercialization of R&D, public private partnerships, talent attraction and other issues of importance for the realization of our vision for the Medicon Valley cluster. Last year’s annual meeting titled “Life Science in Medicon Valley – global outlook with regional impact”, was attended by 250+ prominent regional life science stakeholders.
Participation Participation is free of charge for members of MVA and members of the press. Non-members can access the event by invitation only. Please contact us at nm@mva.org. Registration ends on November 5, 2021.
SPONSORS
 |
 |
 |
 |
 |
 |
 |
 |